Combination therapy of omalizumab with house dust mite immunotherapy in chronic spontaneous urticaria associated with sensitization to dust mites-case series. Indian J Case Reports [Internet]. 2021 Nov. 1 [cited 2026 Aug. 19];7(11):469-72. Available from: https://mansapublishers.com/ijcr/article/view/3107